Chronic Kidney Disease Clinical Trial
Official title:
Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease
The relationship between elevated phosphorus levels and morbidity and mortality in patients with chronic kidney disease (CKD) is well recognized, and dietary phosphorus restriction is a mainstay of phosphate management. Current study is an effort to test the effect of a web-based nutritional educational intervention, Kidney School(KS), to improve phosphorous knowledge and control phosphorous intake in CKD patients.
The relationship between elevated phosphorous level in the severity of Chronic kidney
disease(CKD) is well documented. However, appropriate control of phosphate intake remains
sub-par, due in part to the difficulties that patients have understanding phosphate content
in foods.
Randomized trials have shown that intensive, individualized dietary counseling can improve
patient knowledge about phosphorus and help control hyperphosphatemia; however, maintaining
this level of counseling is time-consuming, costly, and impractical. Given the recognized
nephrology workforce shortage, there is a crucial need for systems to fill this gap with
novel technologies to educate patients, and it is vital that a better understanding of the
effects of novel nutritional intervention counseling methods on patient knowledge,
nutritional intake and nutritional status be evaluated in CKD patients.
Furthermore, to effectively engage in the patient side of the education process, those who
receive it, the patients, must be able to comprehend information and draw on it for
decision-making. Novel educational interventions may be better suited than traditional
methods to circumvent literacy limitations. Therefore, it is vital to assess the relation of
functional health literacy of this population in both traditional and emerging educational
venues.
Kidney School (KS, http://www.kidneyschool.org) is an online, personalized, interactive
self-management learning center created by the Madison, WI based Medical Education Institute
(MEI) and organized into fifteen 20-30 minute modules, each focused on a different topic
related to kidney disease and its treatment, including nutrition. Content is based on 10
years of research conducted by the Life Options Rehabilitation Program, with internal and
external expert review. The nutrition module is tailored for patients with or without
diabetes.
The importance of phosphorus control for patients with CKD has traditionally been vital to
prevent bone disease. More recently it is recognized that poor phosphorus control correlates
with cardiovascular disease, of which patients with CKD carry an enormous burden. Similarly,
there has recently been much attention to circulating endothelial cells (CECs) as a novel
marker for cardiovascular risk in this population. While the ultimate test would be to
determine if controlling phosphorus impacts on cardiovascular events, that is beyond the
scope of this project. Therefore, we propose to measure levels of CECs as an intermediary
step toward cardiovascular events, in correlation to phosphorus intake.
Following enrollment and informed consent, subjects will be randomized to one of two arms
[group1: usual care; group 2: usual care plus Kidney School (KS)].
Kidney School (KS, http://www.kidneyschool.org) is an online, personalized, interactive
self-management learning center created by the Madison, WI based Medical Education Institute
(MEI) and organized into fifteen 20-30 minute modules, each focused on a different topic
related to kidney disease and its treatment, including nutrition. Content is based on 10
years of research conducted by the Life Options Rehabilitation Program, with internal and
external expert review. The nutrition module is tailored for patients with or without
diabetes.
Proprietary Information. The mission of the non-profit MEI is to help people with chronic
diseases learn to manage and improve their health, through research and education. The MEI
believes charging a fee for educational materials can be a barrier between patients and the
information they need to live successfully with a chronic disease. All MEI-developed patient
education materials are therefore free. KS is entirely proprietary to the MEI, but will
continue to be available free of charge via the Internet. KS is fully compliant with HIPAA
standards.
The SF-12 Health Survey version 2 is a 12-item measure of health related quality of life.
Widely used in research in a variety of disease states, including CKD, it provides physical
and mental component summary scores with a strong concordance with the lengthier SF-36. Given
that we will be administering multiple cognitive and behavioral surveys to subjects, the
shorter version will be used.
Kidney Disease Self-Management Survey (KDSMS). Developed by MEI, the KDSMS is a 58-item
Likert scale with 6 subscales, based on theories deemed important for self-management
education in other chronic diseases, including the health belief model, self-efficacy,
behavioral intent, and the transtheoretical model. These theories converge into a
self-management education schema that emphasizes the importance of information, support,
modeling, planning, practice and monitoring, and reflection in patient self-management
education. The 6 subscales are: 1) Self-monitoring, 2) Adjusting to symptoms, 3) Lifestyle
behaviors, 4) Medication-taking, 5) Information seeking, 6) Doctor/patient communication.
24 hour recall diaries - After collecting the information from subjects, nutrient analysis
will be performed using The Food Processor SQL Nutrition Software (ESHA Research, Salem,
Oregon).
The study instruments will all performed for research purposes. While some of them (the
S-TOFHLA, 3-Day Dietary Diaries) have been used as part of patient care, this is not routine,
and it is not done at our facilities.
Lab work collected will consist of serum phosphorus, calcium and intact-parathyroid hormone
levels. As these are routinely collected prior to or during a regular CKD clinic visit, the
study coordinator will check to see if this data is already available, and will not duplicate
this blood work if it is. In addition, all subjects will have blood drawn (30 ml) for
assessment of circulating endothelial cells (CECs), a novel marker for vascular damage.
Following baseline data collection, group 1 will continue with their scheduled clinic visit,
while group 2 will spend approximately 30 minutes completing the KS nutrition module at a
dedicated computer education station at the UW Kidney Clinic. The study coordinator will
bring up the KS nutrition module (tailored for diabetes as a co-morbidity if appropriate).
After completion of the KS nutrition module, patients will receive a personalize action plan,
and then proceed with their scheduled clinic visit.
All subjects will then be asked to return in 30-60 days to repeat some of the survey
information and blood work.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |